Taevas
BrazilPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in Brazil
Navigating the complex global landscape for product registration requires a robust market access strategy. Taevas Life Sciences ensures your innovative therapies and devices achieve optimal market entry and sustained commercial success across diverse regu
Market
Global
Industry
Product-Registration
Regulator
Global Regulatory Authorities
Timeline
8-12 weeks (initial strategy)
Deliverables
Market Access Strategy Report, P&R Dossier Support, HTA Submissions
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory & Market Landscape Analysis
We conduct in-depth analysis of regulatory requirements, health technology assessment (HTA) frameworks, and market dynamics across target geographies. This foundational insight informs a robust market access strategy tailored to each region.
Comprehensive country-specific regulatory mapping
Assessment of HTA and reimbursement policies
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Scope Definition
We begin with a thorough understanding of your product, target markets, and strategic objectives. This initial phase defines the scope of our engagement and identifies critical success factors.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Payer Scrutiny
Global payers are increasingly demanding robust clinical and economic evidence to justify product value, making sophisticated HTA and reimbursement strategies critical for market entry.
Regional Divergence in Regulations
The fragmentation of regulatory and HTA requirements across different countries necessitates a highly localized yet globally coordinated market access approach to ensure efficient product registration and uptake.
Importance of Early Engagement
Proactive engagement with regulatory bodies, HTA agencies, and patient groups early in the development cycle significantly enhances the likelihood of successful product registration and optimal market access.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining target markets, regulatory pathways, HTA requirements, and recommended pricing and reimbursement strategies.
Value Story & Evidence Generation Plan
A strategic framework detailing the product's unique value proposition and a roadmap for generating compelling clinical and economic evidence.
Payer Landscape & Competitive Intelligence Report
Detailed analysis of payer policies, reimbursement trends, and competitor strategies within your key global markets.
Market Access Dossier (HTA/P&R) Support
Expert guidance and review for the preparation and submission of Health Technology Assessment and Pricing & Reimbursement dossiers.
Who This Is For
Use Cases
Biotech Startup
First Global Launch of an Orphan Drug
A biotech startup with a novel orphan drug faced challenges in navigating disparate regulatory and reimbursement landscapes across Europe and Asia. Taevas Life Sciences developed a harmonized market access strategy, focusing on early HTA engagement and patient advocacy.
Outcome
Achieved successful registration and premium reimbursement in 8 key markets within 18 months.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your product registration into sustained market success. Our expertise ensures your innovations reach patients efficiently and effectively worldwide.
Accelerated market entry
Optimized pricing and reimbursement
Reduced regulatory hurdles
Maximized product value